Therefore, for the treatment of sepsis and other diseases, inhibiting HMGB1active release and/or blocking HMGB1 pro-inflammatory activities could be more effective ways to help patients achieve better therapeutic outcomes. The gene discussed is HMGB1; the disease is Sepsis.